Actionnariat et activité des initiés pour Ovid Therapeutics Inc. (OVID): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.68 |
| Capitalisation | $500M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $51.9M | $87.1M | $36.5M | $41.9M | $72.0M | $187.8M | $44.9M | $27.0M | $26.3M | $13.2M |
| Placements à Court Terme | 0 | 0 | $5.0M | $34.8M | 0 | 0 | $84.1M | $78.8M | $26.8M | $56.5M |
| Créances | $7369 | 0 | 0 | $1.1M | $141763 | 0 | 0 | 0 | 0 | 0 |
| Stocks | $242673 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $52.4M | $88.6M | $44.3M | $79.8M | $74.8M | $190.5M | $131.4M | $109.6M | $55.9M | $90.4M |
| Immobilisations Corporelles | $43591 | $51775 | $69867 | $68363 | $135620 | $242757 | $16.1M | $14.7M | $13.2M | 0 |
| Goodwill | 0 | 0 | 0 | -$247 | $100 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $110074 | $124194 | $391872 | $467247 | $318900 | $164000 | $222100 | $200000 | $92000 | 0 |
| Actifs Totaux | $53.0M | $89.5M | $47.6M | $80.8M | $75.9M | $194.5M | $155.3M | $144.0M | $92.2M | $150.9M |
| Dettes Fournisseurs | $857169 | $2.0M | $3.8M | $3.3M | $5.4M | $7.1M | $2.0M | $3.7M | $3.2M | $2.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $3.7M | $6.0M | $8.8M | $10.5M | $22.1M | $14.8M | $7.0M | $11.5M | $10.5M | $8.3M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $3.7M | $6.0M | $8.8M | $10.8M | $32.3M | $14.8M | $23.0M | $56.2M | $23.9M | $20.3M |
| Réserves | -$61.8M | -$100.7M | -$152.7M | -$213.2M | -$294.2M | -$171.4M | -$225.5M | -$277.9M | -$304.3M | -$321.7M |
| Capitaux Propres | $49.3M | $83.4M | $38.8M | $70.0M | $43.6M | $179.7M | $132.3M | $87.8M | $68.2M | $130.7M |
| Dette Totale | 0 | 0 | 0 | 0 | 0 | 0 | $16.5M | $16.0M | $14.8M | $13.4M |
| Dette Nette | -$51.9M | -$87.1M | -$41.5M | -$76.7M | -$72.0M | -$187.8M | -$112.5M | -$89.8M | -$38.3M | -$56.2M |
| Fonds de Roulement | $48.7M | $82.6M | $35.4M | $69.3M | $52.8M | $175.7M | $124.4M | $98.1M | $45.4M | $82.2M |
Santé financière
| Dette / Capitaux propres | 0.06 |
| Ratio de liquidité | 12.39 |
Rentabilité
| Rentabilité des capitaux propres | -23.64% |
| Rentabilité du capital investi | -26.11% |
| Rentabilité des actifs | -14.87% |
| Marge brute | 100.00% |
| Marge opérationnelle | -3686.67% |
| Marge nette | -2178.90% |
Entreprises liées: CLNN · CNTB · CNTX · IFRX · IMA · KLRS · MGNX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de OVID: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions